The Launch Execution Gap

In this episode of Bench to Boardroom, we examine why so many biopharma launches fail to meet expectations despite unprecedented access to data, analytics, and technology. Using the lens of the approximately 34% of U.S. launches that miss forecast and the widespread industry view that poor data are a key contributor, the discussion explores the deeper root causes of underperformance -- including the inability to translate analytics into field action, fragmented data ecosystems across clinical, regulatory, market access, and commercial functions, and slow organizational activation. The episode argues that while AI is not a cure-all, organizations that thoughtfully integrate AI into a connected decision-making ecosystem can improve execution, accelerate ROI, and create meaningful competitive advantage. Ultimately, success will increasingly belong to leaders who transform intelligence into action faster and more effectively than their competitors.